{
    "balance": {
        "data": [
            "Consolidated Balance Sheets\t4\tConsolidated Statements of Cash Flows\t5\tNotes to Consolidated Financial Statements\t6\tItem 2.\tManagement s Discussion and Analysis of Financial Condition and Results of Operations\t25\tItem 3.\tQuantitative and Qualitative Disclosure About Market Risk\t39\tItem 4.\tControls and Procedures\t39\tPART II OTHER INFORMATION\tItem 1.\tLegal Proceedings\t39\tItem 1A.\tRisk Factors\t39\tItem 2.\tUnregistered Sales of Equity Securities and Use of Proceeds\t39\tItem 6.\tExhibits\t40\tSummary of Abbreviated Terms\t41\tSignatures\t42\t*\tIndicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.\tPART I FINANCIAL INFORMATION\tItem 1. FINANCIAL STATEMENTS\tBRISTOL-MYERS SQUIBB COMPANY\tCONSOLIDATED STATEMENTS OF EARNINGS\tDollars in Millions, Except Per Share Data\t(UNAUDITED)\tThree Months Ended March 31,\tEARNINGS\t2019\t2018\tNet product sales\t$\t5,713\t$\t4,972\tAlliance and other revenues\t207\t221\tTotal Revenues\t5,920\t5,193\tCost of products sold\t1,844\t1,584\tMarketing, selling and administrative\t1,006\t980\tResearch and development\t1,351\t1,250\tOther income (net)\t(260\t)\t(400\t)\tTotal Expenses\t3,941\t3,414\tEarnings Before Income Taxes\t1,979\t1,779\tProvision for Income Taxes\t264\t284\tNet Earnings\t1,715\t1,495\tNoncontrolling Interest\t5\t9\tNet Earnings Attributable to BMS\t$\t1,710\t$\t1,486\tEarnings per Common Share\tBasic\t$\t1.05\t$\t0.91\tDiluted\t1.04\t0.91\tCONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME\tDollars in Millions\t(UNAUDITED)\tThree Months Ended March 31,\tCOMPREHENSIVE INCOME\t2019\t2018\tNet Earnings\t$\t1,715\t$\t1,495\tOther Comprehensive Income/(Loss), net of taxes and reclassifications to earnings:\tDerivatives qualifying as cash flow hedges\t14\t(19\t)\tPension and postretirement benefits\t49\t129\tAvailable-for-sale securities\t26\t(26\t)\tForeign currency translation\t29\t5\tOther Comprehensive Income/(Loss)\t118\t89\tComprehensive Income\t1,833\t1,584\tComprehensive Income Attributable to Noncontrolling Interest\t5\t9\tComprehensive Income Attributable to BMS\t$\t1,828\t$\t1,575\tThe accompanying notes are an integral part of these consolidated financial statements.\t3\tBRISTOL-MYERS SQUIBB COMPANY\tCONSOLIDATED BALANCE SHEETS\tDollars in Millions\t(UNAUDITED)\tASSETS\tMarch 31,\t2019\tDecember 31,\t2018\tCurrent Assets:\tCash and cash equivalents\t$\t7,335\t$\t6,911\tMarketable securities\t1,429\t1,973\tReceivables\t5,704\t5,965\tInventories\t1,283\t1,195\tPrepaid expenses and other\t1,342\t1,116\tTotal Current Assets\t17,093\t17,160\tProperty, plant and equipment\t4,985\t5,027\tGoodwill\t6,536\t6,538\tOther intangible assets\t1,026\t1,091\tDeferred income taxes\t1,380\t1,371\tMarketable securities\t1,233\t1,775\tOther assets\t2,581\t2,024\tTotal Assets\t$\t34,834\t$\t34,986\tLIABILITIES\tCurrent Liabilities:\tShort-term debt obligations\t$\t381\t$\t1,703\tAccounts payable\t1,976\t1,892\tAccrued liabilities\t5,856\t6,489\tDeferred income\t103\t172\tIncome taxes payable\t525\t398\tTotal Current Liabilities\t8,841\t10,654\tDeferred income\t448\t468",
            "CONSOLIDATED BALANCE SHEETS\tDollars in Millions\t(UNAUDITED)\tASSETS\tMarch 31,\t2019\tDecember 31,\t2018\tCurrent Assets:\tCash and cash equivalents\t$\t7,335\t$\t6,911\tMarketable securities\t1,429\t1,973\tReceivables\t5,704\t5,965\tInventories\t1,283\t1,195\tPrepaid expenses and other\t1,342\t1,116\tTotal Current Assets\t17,093\t17,160\tProperty, plant and equipment\t4,985\t5,027\tGoodwill\t6,536\t6,538\tOther intangible assets\t1,026\t1,091\tDeferred income taxes\t1,380\t1,371\tMarketable securities\t1,233\t1,775\tOther assets\t2,581\t2,024\tTotal Assets\t$\t34,834\t$\t34,986\tLIABILITIES\tCurrent Liabilities:\tShort-term debt obligations\t$\t381\t$\t1,703\tAccounts payable\t1,976\t1,892\tAccrued liabilities\t5,856\t6,489\tDeferred income\t103\t172\tIncome taxes payable\t525\t398\tTotal Current Liabilities\t8,841\t10,654\tDeferred income\t448\t468\tIncome taxes payable\t3,084\t3,043\tPension and other liabilities\t1,509\t1,048\tLong-term debt\t5,635\t5,646\tTotal Liabilities\t19,517\t20,859\tCommitments and contingencies\tEQUITY\tBristol-Myers Squibb Company Shareholders  Equity:\tPreferred stock\t \t \tCommon stock\t221\t221\tCapital in excess of par value of stock\t2,103\t2,081\tAccumulated other comprehensive loss\t(2,644\t)\t(2,762\t)\tRetained earnings\t35,109\t34,065\tLess cost of treasury stock\t(19,571\t)\t(19,574\t)\tTotal Bristol-Myers Squibb Company Shareholders  Equity\t15,218\t14,031\tNoncontrolling interest\t99\t96\tTotal Equity\t15,317\t14,127\tTotal Liabilities and Equity\t$\t34,834\t$\t34,986\tThe accompanying notes are an integral part of these consolidated financial statements.\t4\tBRISTOL-MYERS SQUIBB COMPANY\tCONSOLIDATED STATEMENTS OF CASH FLOWS\tDollars in Millions\t(UNAUDITED)\tThree Months Ended March 31,\t2019\t2018\tCash Flows From Operating Activities:\tNet earnings\t$\t1,715\t$\t1,495\tAdjustments to reconcile net earnings to net cash provided by operating activities:\tDepreciation and amortization, net\t170\t143\tDeferred income taxes\t2\t160\tStock-based compensation\t53\t55\tImpairment charges\t45\t80\tPension settlements and amortization\t66\t50\tDivestiture gains and royalties\t(166\t)\t(255\t)\tAsset acquisition charges\t \t60\tEquity investment gains\t(175\t)\t(15\t)\tOther adjustments\t(6\t)\t(14\t)\tChanges in operating assets and liabilities:\tReceivables\t236\t219\tInventories\t35\t(4\t)\tAccounts payable\t136\t(241\t)\tDeferred income\t15\t23\tIncome taxes payable\t196\t114\tOther\t(932\t)\t(695\t)\tNet Cash Provided by Operating Activities\t1,390\t1,175\tCash Flows From Investing Activities:\tSale and maturities of marketable securities\t1,350\t442\tPurchase of marketable securities\t(242\t)\t(285\t)\tCapital expenditures\t(204\t)\t(239\t)\tDivestiture and other proceeds\t171\t375\tAcquisition and other payments\t(15\t)\t(336\t)\tNet Cash Provided by/(Used in) Investing Activities\t1,060\t(43\t)\tCash Flows From Financing Activities:\tShort-term debt obligations, net\t(73\t)\t(344\t)\tRepayment of long-term debt\t(1,250\t)\t \tRepurchase of common stock\t \t(167\t)\tDividends\t(669\t)\t(653\t)\tOther\t(37\t)\t(58\t)\tNet Cash Used in Financing Activities\t(2,029\t)\t(1,222\t)\tEffect of Exchange Rates on Cash and Cash Equivalents\t3\t11\tNet Increase/(Decr"
        ],
        "timestamp": "2025-01-21_09-31-34"
    }
}